53 -3 (77) 2025 - Alimkhodzhayeva L.T., Akhmadzhanova O.M. - MORPHOLOGICAL CHARACTERISTICS OF THE EXPRESSION OF E-CADHERIN, P-CATENIN AND CYTOKERATINS IN THE DIAGNOSIS AND PROGNOSIS OF INFILTRATING BREAST CANCER

MORPHOLOGICAL CHARACTERISTICS OF THE EXPRESSION OF E-CADHERIN, P-CATENIN AND CYTOKERATINS IN THE DIAGNOSIS AND PROGNOSIS OF INFILTRATING BREAST CANCER

Alimkhodzhayeva L.T. - Republic of specialized oncology and radiology scientific and practical medical center Uzbekistan

Akhmadzhanova O.M. - Republic of specialized oncology and radiology scientific and practical medical center Uzbekistan

Resume

According to most experts, the prognosis of infiltrating breast cancer (IRCC) is determined by its early diagnosis, which requires careful screening among women at increased risk, which primarily includes patients with precancerous breast lesions. In recent years, the immunohistochemistry method has become widely used by researchers in the study of breast cancer for early diagnosis and prognosis. However, in most published studies using this method, a limited number of markers does not allow us to fully clarify the biological profile of the diseases under study, there is no data on their prognostic significance, and a comprehensive diagnostic algorithm combining morphological and immunohistochemical criteria has not been defined.

Keywords: Breast cancer, immunohistochemistry, dysplasia, invasion.

First page

286

Last page

292

For citation:Alimkhodzhayeva L.T., Akhmadzhanova O.M. - MORPHOLOGICAL CHARACTERISTICS OF THE EXPRESSION OF E-CADHERIN, P-CATENIN AND CYTOKERATINS IN THE DIAGNOSIS AND PROGNOSIS OF INFILTRATING BREAST CANCER//New Day in Medicine 3(77)2025 286-292 https://https://newdayworldmedicine.com/en/new_day_medicine/3-77-2025

List of References

1. Бессмертный Д.В. Дифференциальные критерии при клинико-морфологических параллелях прогноза рака молочной железы железы: автореф. дис. Канд. мед. наук. - Ростов/Дону, 2012; 24 с.
2. Бусько Екатерина Александровна Мультипараметрическое ультразвуковое исследование в ранней диагностике и мониторинге лечения рака молочной железы: автореф. дис… докт. мед. наук. - СПб, 2021; 43 с.
3. Ковылина М.В. Клиническая и морфологическая характеристика раковых и предраковых заболеваний молочной железы: автореф. дис… канд. мед. наук.-М., 2007.- 25с .
4. Беркут М.В. Предиктивная роль патоморфологического и молекулярного типирования при радикальном лечении больных раком молочной железы высокого риска. Автореф. дис… канд. мед. наук. 2020; 26 с.
5. Охриц Валерия Евгеньевна Диагностические и прогностические факторы рака молочной железы: Автореф. дис… канд. мед,наук. 2012; 24 с.
6. Kristiansen G. Markers of clinical utility in the differential diagnosis and prognosis of breast cancer. // Mod Pathol. 2018 Jan;31(S1):143-155.
7. Perrone G., Altomare V., Zagami M. et al. Caveolin-1 expression in human breast lobular cancer progression // Mod. Pathol. 2009;22(1):71-78.
8. Perrone G., Zagami M., Altomare V. et al. COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast // Virchows Arch. 2007;451(6):1039-1045.
9. Polom K., Murawa D., Pawelska A., Murawa P. Atypical lobular hyperplasia and lobular carcinoma in situ without other high-risk lesions diagnosed on vacuum-assisted core needle biopsy. The problem of excisional biopsy // Tumori. 2009;95(1):32-35.
10. Shakhanova Shakhnoza, Rakhimov Nodir, Zaripova Parvina. Breast tumors in adolescent girls // Journal of Biomedicine and Practice. 2022;7(3):266-273.
11. Pope T.L., Fechner R.E., Wilhelm M.C. et al. Lobular carcinoma in situ of the breast: mammographic features // Radiology 1988;168:63-66.
12. Sanguedolce F, Cormio A, Musci G, Troiano F, Carrieri G, Bufo P, Cormio L. Typing the atypical: Diagnostic issues and predictive markers in suspicious breast lesions. // Crit Rev Clin Lab Sci. 2017 Aug;54(5):309-325.

    file

    download